About Locust Walk
Locust Walk is a global life science transaction firm that integrates strategy, market analytics, and transaction capabilities from both biopharma and medtech perspectives on a global scale. The company is based in Boston, Massachusetts.
Latest Locust Walk News
May 9, 2023
News provided by Share this article Share this article CAMBRIDGE, Mass., May 9, 2023 /PRNewswire/ -- Kernal Bio, a venture-backed biotech company developing mRNA 2.0 immunotherapies, announced today that Yusuf Erkul, M.D., Co-founder & CEO, will present the company's novel mRNA 2.0 platform at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 1:00 p.m. ET. The Locust Walk RNA Innovation Conference is hosted in partnership with Dr. Frank Slack, Director of the Beth Israel RNA Medicine Initiative, and Dr. Phil Zamore, Director of the UMass Chan RNA Medicine Institute. Locust Walk is hosting a virtual one-day investor and partner conference exploring innovations in RNA research and development, including: Protein expression, RNA editing, RNA-mediated protein & transcriptome regulation, RNA targeting SMOLs, translation inhibition and novel delivery approaches. The event will showcase cutting-edge science, industry trends, and high-value opportunities in next-generation in RNA R&D. The format will include keynote speakers, company presentations, and panel discussions featuring leaders and luminaries from industry, academia, and the investment community. About Kernal Bio At Kernal Bio, we aim to harness the power of our mRNA technology to provide cancer patients with treatments that give them the best chance of beating their disease — while eliminating as many common side effects as possible. Our unique inside-out approach attacks diseases like cancer at the cellular level. Our proprietary mRNA technology is engineered to move in stealth, undetected by the immune system, and encrypted to home in on cancer cells, making it distinctively onco-selective. Thus, we maximize the potential to improve patient outcomes compared to existing synthetic mRNA. Please visit our website at www.kernalbio.com and on social media: Facebook, Twitter and LinkedIn. About the mRNA 2.0 Platform Kernal Bio established a machine learning-backed computational pipeline to analyze transcriptome and translatome datasets across cell types and disease state to discover cell-specific mRNA sequence features. These features are then deployed during synthetic mRNA design to enable cell-specific therapeutic mRNAs. The first therapeutic products of the mRNA 2.0 platform, including KR-335, initially focus on immuno-oncology. SOURCE Kernal Biologics
Locust Walk Frequently Asked Questions (FAQ)
Where is Locust Walk's headquarters?
Locust Walk's headquarters is located at 200 Clarendon Street, Boston.
Who are Locust Walk's competitors?
Competitors of Locust Walk include Nyquist Data and 4 more.
Compare Locust Walk to Competitors
VertMarkets is an online media company that provides B2B print and online platforms. It helps B2B companies connect with their target audiences in the life sciences, electronics, water, and IT niche markets. It was founded in 2002 and is based in Erie, Pennsylvania.
PubGrade provides a digital advertising platform for the life sciences, combining strong insights into biomedical research corpora and their readership with functionality to make these insights actionable towards digital marketing and sales. It offers life science-specific contextual targeting, reporting, and analytics with unparalleled precision and access to custom-tailored audiences. The company was founded in 2013 and is based in Aachen, Germany.
Pharma’s Almanac operates as a pharmaceutical company. It offers an in-depth analysis of pharma’s most intensive markets, active business sectors, and major players. The company was founded in 2015 and is based in New York, New York.
Pagan Research is an online B2B database and business intelligence website. It delivers quality data for the US, Asia, and EU regions' startups, recent fundings, exits, and more. The company was founded in 2016 and is based in Boston, Massachusetts.
That’s Nice provides research-driven marketing and brand management to companies within the life sciences. It provides brand development, industry-leading research, strategy, design, and business services. The company was founded in 1995 and is based in New York, New York.